Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Multiple Myeloma × Urine Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Dexamethasone 88 Bortezomib 52 Cyclophosphamide 44 Lenalidomide 40 Calcium Dobesilate 36 pomalidomide 26 Melphalan 26 fludarabine 22 Filgrastim 20 carfilzomib 19 fludarabine phosphate 15 daratumumab 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Granulocyte Colony-Stimulating Factor 13 Antilymphocyte Serum 13 dexamethasone acetate 12 Thalidomide 12 Cyclosporine 12 Tacrolimus 10 Peripheral Blood Stem Cell Transplantation 10 dexamethasone 21-phosphate 9 auricularum 9 Radiotherapy 9 Busulfan 9 belantamab mafodotin 8 Etoposide 8 pembrolizumab 7 ixazomib 7 Stem Cell Transplantation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04111809 2025-09-25

AMBROBiMM

Assistance Publique - Hôpitaux de Paris

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡